CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface
- PMID: 27035969
- PMCID: PMC4839449
- DOI: 10.1073/pnas.1523745113
CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface
Abstract
Corticotropin releasing factor binding protein (CRF-BP) was originally recognized as CRF sequestering protein. However, its differential subcellular localization in different brain nuclei suggests that CRF-BP may have additional functions. There is evidence that CRF-BP potentiates CRF and urocortin 1 actions through CRF type 2 receptors (CRF2R). CRF2R is a G protein-coupled receptor (GPCR) that is found mainly intracellularly as most GPCRs. The access of GPCRs to the cell surface is tightly regulated by escort proteins. We hypothesized that CRF-BP binds to CRF2R, exerting an escort protein role. We analyzed the colocalization of CRF-BP and CRF2R in cultured rat mesencephalic neurons, and the localization and interaction of heterologous expressed CRF-BP and CRF2αR in yeast, human embryonic kidney 293, and rat pheochromocytoma 12 cells. Our results showed that CRF-BP and CRF2R naturally colocalize in the neurites of cultured mesencephalic neurons. Heterologous expression of each protein showed that CRF-BP was localized mainly in secretory granules and CRF2αR in the endoplasmic reticulum. In contrast, CRF-BP and CRF2αR colocalized when both proteins are coexpressed. Here we show that CRF-BP physically interacts with the CRF2αR but not the CRF2βR isoform, increasing CRF2αR on the cell surface. Thus, CRF-BP emerges as a GPCR escort protein increasing the understanding of GPCR trafficking.
Keywords: CRH; accessory protein; escort protein; protein interactions.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Molecular Modeling of Structures and Interaction of Human Corticotropin-Releasing Factor (CRF) Binding Protein and CRF Type-2 Receptor.Front Endocrinol (Lausanne). 2018 Feb 20;9:43. doi: 10.3389/fendo.2018.00043. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29515519 Free PMC article.
-
Corticotropin-releasing factor type-2 receptor and corticotropin-releasing factor-binding protein coexist in rat ventral tegmental area nerve terminals originated in the lateral hypothalamic area.Eur J Neurosci. 2016 Jan;43(2):220-9. doi: 10.1111/ejn.13113. Epub 2015 Nov 28. Eur J Neurosci. 2016. PMID: 26503565
-
Corticotropin-releasing factor binding protein enters the regulated secretory pathway in neuroendocrine cells and cortical neurons.Neuropeptides. 2011 Aug;45(4):273-9. doi: 10.1016/j.npep.2011.05.002. Epub 2011 May 31. Neuropeptides. 2011. PMID: 21624661
-
Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.Front Neuroendocrinol. 1995 Oct;16(4):362-82. doi: 10.1006/frne.1995.1013. Front Neuroendocrinol. 1995. PMID: 8557170 Review.
-
Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.Mol Psychiatry. 1996 Sep;1(4):265-77. Mol Psychiatry. 1996. PMID: 9118350 Review.
Cited by
-
Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety.Mol Psychiatry. 2023 Nov;28(11):4742-4755. doi: 10.1038/s41380-021-01141-x. Epub 2021 May 25. Mol Psychiatry. 2023. PMID: 34035479 Free PMC article.
-
Interaction Between Stress and Addiction: Contributions From Latin-American Neuroscience.Front Psychol. 2018 Dec 21;9:2639. doi: 10.3389/fpsyg.2018.02639. eCollection 2018. Front Psychol. 2018. PMID: 30622500 Free PMC article. Review.
-
Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.Int Rev Neurobiol. 2017;136:5-51. doi: 10.1016/bs.irn.2017.06.004. Epub 2017 Aug 7. Int Rev Neurobiol. 2017. PMID: 29056155 Free PMC article. Review.
-
Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.Stress. 2017 Sep;20(5):449-464. doi: 10.1080/10253890.2017.1322575. Epub 2017 May 18. Stress. 2017. PMID: 28436309 Free PMC article. Review.
-
Immunolocalization of kappa opioid receptors in the axon initial segment of a group of embryonic mesencephalic dopamine neurons.IBRO Neurosci Rep. 2022 May 11;12:411-418. doi: 10.1016/j.ibneur.2022.05.002. eCollection 2022 Jun. IBRO Neurosci Rep. 2022. PMID: 35746971 Free PMC article.
References
-
- Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev. 1990;15(2):71–100. - PubMed
-
- Bale TL, Vale WW. CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 2004;44:525–557. - PubMed
-
- Herman JP, et al. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003;24(3):151–180. - PubMed
-
- Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol. 1993;40(5):573–629. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources